J Neurosci:程乐平等脊髓背角神经递质受体基因表达研究获进展

2012-07-03 上海生科院 上海生科院

6月20号,《神经科学杂志》(The Journal of Neuroscience) 发表了中科院上海生科院神经所神经发育及其调控机理研究组的论文《Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal s

6月20号,《神经科学杂志》(The Journal of Neuroscience) 发表了中科院上海生科院神经所神经发育及其调控机理研究组的论文《Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord》。该项工作是由研究生国祯、赵丛玲和黄梦归等在程乐平研究员的指导下共同完成的。同期的 The Journal of Neuroscience 发表了题为“转录因子驱动一些独特的神经环路相关蛋白的表达”(Transcription Factors Drive Distinct Neural Circuit Proteins)的评论,对该项工作进行了介绍。

弄清神经递质、神经肽及其受体在不同类型神经元中的表达模式对于理解神经系统中神经环路的形成具有重要意义。脊髓背角在躯体感觉信息从外周向大脑传递的过程中起重要作用。依照所使用的神经递质的不同,脊髓背角神经元可分为兴奋性的谷氨酸能神经元与抑制性的γ-氨基丁酸能神经元。一些神经肽也特异地表达在谷氨酸能神经元或γ-氨基丁酸能神经元中。我们及他人的工作曾报道一些转录因子决定脊髓背角谷氨酸能神经元与γ-氨基丁酸能神经元中神经递质与神经肽的表达。然而,是否有一些神经递质与神经肽的受体特异地表达在谷氨酸能神经元或γ-氨基丁酸能神经元中,他们的表达受哪些基因调控,目前的报道还很少。

利用原位杂交及免疫组化染色技术,作者发现多种神经递质与神经肽受体基因特异地表达在谷氨酸能神经元中。通过分析基因敲除小鼠的表型,发现这些受体的表达依赖于决定谷氨酸能神经元命运的转录因子Tlx1/3。转录因子Lbx1与Ptf1a同时也对这些受体在谷氨酸能神经元中的表达起调控作用。进一步实验表明,多种神经递质与神经肽受体基因特异地表达在γ-氨基丁酸能神经元中,它们的表达依赖于决定γ-氨基丁酸能神经元命运的转录因子Ptf1a;转录因子Pax2与Tlx1/3也对这些受体基因在γ-氨基丁酸能神经元中的表达起调控作用。

该研究结果揭示了决定神经元命运的转录因子同时也决定了神经元中特异表达的神经递质与神经肽受体的表达。这为认识神经元的发育调控及神经环路的形成机制提供了新的视角。

该工作得到了科技部及中科院项目的资助。

doi:10.1523/​JNEUROSCI.6301-11.2012
PMC:
PMID:

Tlx1/3 and Ptf1a Control the Expression of Distinct Sets of Transmitter and Peptide Receptor Genes in the Developing Dorsal Spinal Cord

Zhen Guo1, Congling Zhao2, Menggui Huang2, Tianwen Huang2, Mingran Fan2, Zhiqin Xie1, Ying Chen1, Xiaolin Zhao2, Guannan Xia1, Junlan Geng2, and Leping Cheng2

Establishing the pattern of expression of transmitters and peptides as well as their receptors in different neuronal types is crucial for understanding the circuitry in various regions of the brain. Previous studies have demonstrated that the transmitter and peptide phenotypes in mouse dorsal spinal cord neurons are determined by the transcription factors Tlx1/3 and Ptf1a. Here we show that these transcription factors also determine the expression of two distinct sets of transmitter and peptide receptor genes in this region. We have screened the expression of 78 receptor genes in the spinal dorsal horn by in situ hybridization. We found that receptor genes Gabra1, Gabra5, Gabrb2, Gria3, Grin3a, Grin3b, Galr1, and Npy1r were preferentially expressed in Tlx3-expressing glutamatergic neurons and their derivatives, and deletion of Tlx1 and Tlx3 resulted in the loss of expression of these receptor genes. Furthermore, we obtained genetic evidence that Tlx3 uses distinct pathways to control the expression of receptor genes. We also found that receptor genes Grm3, Grm4, Grm5, Grik1, Grik2, Grik3, and Sstr2 were mainly expressed in Pax2-expressing GABAergic neurons in the spinal dorsal horn, and their expression in this region was abolished or markedly reduced in Ptf1a and Pax2 deletion mutant mice. Together, our studies indicate that Tlx1/3 and Ptf1a, the key transcription factors for fate determination of glutamatergic and GABAergic neurons in the dorsal spinal cord, are also responsible for controlling the expression of two distinct sets of transmitter and peptide receptor genes.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
    2012-07-05 lsndxfj
  6. [GetPortalCommentsPageByObjectIdResponse(id=1803316, encodeId=131618033166a, content=<a href='/topic/show?id=398be5243aa' target=_blank style='color:#2F92EE;'>#程乐平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75243, encryptionId=398be5243aa, topicName=程乐平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Wed Feb 13 05:08:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724194, encodeId=00111e24194fe, content=<a href='/topic/show?id=ddd2e459363' target=_blank style='color:#2F92EE;'>#神经递质受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74593, encryptionId=ddd2e459363, topicName=神经递质受体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a733584701, createdName=gdsun, createdTime=Sat Sep 01 14:08:00 CST 2012, time=2012-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801173, encodeId=bb3218011e33c, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Nov 29 18:08:00 CST 2012, time=2012-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347986, encodeId=1a8c134e98693, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363857, encodeId=4c98136385e46, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468108, encodeId=2c1914681084f, content=<a href='/topic/show?id=1ec7e4592aa' target=_blank style='color:#2F92EE;'>#神经递质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74592, encryptionId=1ec7e4592aa, topicName=神经递质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a506885657, createdName=zxxiang, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]

相关资讯

J App Physio:研究者揭示血液可以承载多少细胞

俗话说“血浓于水”,按字面意义来说也确实如此:与人体生命攸关的血液中约有一半是固体,其中最多的是红血球,约占40%。红血球含有红色素血红蛋白,负责运输氧气。 “令人惊异的是,红血球这一比例不仅在所有人体上基本一致,很多脊椎动物也与此相同”,耶拿大学生物与药学学院生物信息学教授Dr. Stefan Schuster介绍。因此,人们猜测,这一数值是通过进化过程保留下来的理想比例。“如果红血球低于这一

J Immunol:MicroRNA-494对免疫细胞的募集至关重要

髓系来源抑制细胞(myeloid-derived suppressor cells,MDSCs)是未分化成熟的、异质性的、具有免疫抑制功能的髓系细胞群体。MDSCs能有效抑制抗肿瘤免疫反应,有利于肿瘤的血管生成和转移的肿瘤微环境。 到目前为止,肿瘤调节MDSCs的聚集功能分子网络在很大程度上是未知的。近日,Liu Y, 等研究人员在J Immunol杂志上发表论文称microRNA-494的表达

J Mol Cell Biol:徐鹰等发现低氧可以驱动癌症生长

Journal of Molecular Cell Biology(《分子细胞生物学报》)2012年第3期“复杂疾病的系统生物学研究”专辑中发表了一篇美国佐治亚大学生物化学与分子生物学系徐鹰教授关于“Hypoxia and miscoupling between reduced energy efficiency and signaling to cell proliferation drive

J Clin Invest.:新研究揭示肥胖的Wnt途径分子机制

当整个世界在人体水平上对肥胖宣战的时候,密歇根州大学的科学家在微观层面已经取得了令人惊奇发现,这也许可以帮助人类取得这场斗争的胜利。 他们的工作有助于解释为什么肥胖发生时,贮脂细胞会变得更胖,燃烧脂肪的速度会变慢。如果他们的研究结果可以从小鼠推广到人类,这将为抗击肥胖提供一个新的药物靶点。相关研究论文在线发表于6月25日的Journal of Clinical Investigation杂志。

J Nutri:抗性淀粉有助于预防肠癌

澳大利亚联邦科工组织CSIRO的科学家最新发现,摄入抗性淀粉有益于肠道健康,并能预防诱发肠癌的基因损伤。相关研究成果刊登在了近日的国际杂志The Journal of Nutrition上。        肠癌是世界上最常见的恶性肿瘤之一。以往的科学研究认为,饮食结构中纤维摄入量较少是西方人肠癌发病率较高的原因。然而与之相悖的是

J BIOL CHEM:药物所等发现抗癫痫药物VPA可用于治疗自身免疫病

近10多年来,开发老药的新治疗作用,并在此基础上进一步开发出新药,成为了药物研究的重要发展趋势之―。6月25日,Journal of Biological Chemistry在线发表了同济大学生命科学与技术学院、中科院上海药物研究所及华山医院合作研究的有关老药新用的又一新成果。 多发性硬化(Multiple sclerosis,MS)是一种与神经系统相关的自身免疫性疾病,是仅次于创伤的中青年人致